News

Bookmark and Share

This article is in the news archive.

2 x Postdoctoral Fellowships in Multiple Systems Atrophy_Lund University, Sweden

Two Postdoctoral fellowships aimed at exploring glial (oligodendrocyte) toxicity on specific neuronal subtypes and glial cell death observed in Multiple System Atrophy.

The post-doctoral fellows will work on two projects where developing new human in vitro disease models through induced pluripotent stem cell technology, is used to examine the molecular mechanisms underlying glial degeneration and neuronal cell death in Multiple System Atrophy (MSA).

The fellow will be supervised by Assistant Professor Laurent Roybon, in the Cell Stem Cell (CSC) Laboratory for CNS disease modeling, located in the internationally recognized Wallenberg Neuroscience Center at Lund University, Sweden. The environment provides excellent post-doctoral training with state-of the art equipment, numerous guest lectures and workshops and possibilities to interact with industrial partners. The CSC is a newly built laboratory part of the nationally supported strategic research area Multipark (Multidisciplinary research in Parkinson's disease; http://www.med.lu.se/multipark). For further information about our new stem cell laboratory, please see http://www.med.lu.se/english/expmed/research/cell_stem_cell_laboratory_for_cns_disease_modeling_csc.

The duration of the fellowship is 24 months with a possibility of extension. Candidates should have an excellent track record, preferably in research regarding the cell and molecular biology of neurodegenerative disease and development of in vitro cellular models. Experience with pluripotent stem cells and neural stem cells, neural differentiation, multiplex assays, screening plus immunocytochemistry is essential. Candidates also need to be able to communicate well in English and be very good team players.

Please send your application, CV and a list of at least three referees to laurent.roybon@med.lu.se. Starting date: September - November 2012.

Posted on 11/07/2012

Further news

Go to the news index page.